DOI: 10.1055/s-00034916

Nervenheilkunde

References

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF. PREEMPT 1 Chronic Migraine Study Group..
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Cephalalgia 2010;
30: 793-803.

Download Bibliographical Data

Access:
Access: